Medivolve Inc. (MEDVF)
USD 0.01
(133.33%)
USD 0.01
(133.33%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -16.45 Million CAD | 10.39% |
| 2022 | -18.36 Million CAD | -177.82% |
| 2021 | -6.61 Million CAD | 82.5% |
| 2020 | -37.77 Million CAD | -1289.78% |
| 2019 | -2.71 Million CAD | -282.01% |
| 2018 | -711.56 Thousand CAD | -122.46% |
| 2017 | 3.16 Million CAD | 516.11% |
| 2016 | -761.31 Thousand CAD | 32.91% |
| 2015 | -1.13 Million CAD | 44.35% |
| 2014 | -2.03 Million CAD | 65.39% |
| 2013 | -5.89 Million CAD | -78.51% |
| 2012 | -3.3 Million CAD | -79.28% |
| 2011 | -1.84 Million CAD | 9.95% |
| 2010 | -2.04 Million CAD | -13.2% |
| 2009 | -1.8 Million CAD | -42.63% |
| 2008 | -1.26 Million CAD | -808.38% |
| 2007 | -139.38 Thousand CAD | -3.59% |
| 2006 | -134.55 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -931.99 Thousand CAD | 88.87% |
| 2023 Q3 | -3.5 Million CAD | -110.96% |
| 2023 FY | -16.45 Million CAD | 10.39% |
| 2023 Q4 | -8.37 Million CAD | -138.69% |
| 2023 Q1 | -2.91 Million CAD | 26.89% |
| 2023 Q2 | -1.66 Million CAD | 42.89% |
| 2022 Q4 | -3.98 Million CAD | 42.84% |
| 2022 Q3 | -6.96 Million CAD | -16.57% |
| 2022 Q2 | -5.97 Million CAD | -316.09% |
| 2022 FY | -18.36 Million CAD | -177.82% |
| 2022 Q1 | -1.43 Million CAD | -126.61% |
| 2021 FY | -6.61 Million CAD | 82.5% |
| 2021 Q1 | -9.98 Million CAD | 63.29% |
| 2021 Q2 | -8.69 Million CAD | 12.94% |
| 2021 Q3 | 6.85 Million CAD | 178.87% |
| 2021 Q4 | 5.39 Million CAD | -21.23% |
| 2020 Q4 | -27.19 Million CAD | -1084.24% |
| 2020 FY | -37.77 Million CAD | -1289.78% |
| 2020 Q1 | -1.31 Million CAD | -95.56% |
| 2020 Q2 | -6.96 Million CAD | -429.81% |
| 2020 Q3 | -2.29 Million CAD | 67.05% |
| 2019 Q3 | -782.26 Thousand CAD | 3.86% |
| 2019 FY | -2.71 Million CAD | -282.01% |
| 2019 Q1 | -449.6 Thousand CAD | -194.94% |
| 2019 Q2 | -813.69 Thousand CAD | -80.98% |
| 2019 Q4 | -672.67 Thousand CAD | 14.01% |
| 2018 Q4 | -152.44 Thousand CAD | 48.38% |
| 2018 Q3 | -295.33 Thousand CAD | -171.52% |
| 2018 Q2 | -108.77 Thousand CAD | 29.83% |
| 2018 FY | -711.56 Thousand CAD | -122.46% |
| 2018 Q1 | -155 Thousand CAD | -103.81% |
| 2017 Q4 | 4.06 Million CAD | 1654.15% |
| 2017 FY | 3.16 Million CAD | 516.11% |
| 2017 Q3 | -261.82 Thousand CAD | 15.45% |
| 2017 Q2 | -309.67 Thousand CAD | 6.08% |
| 2017 Q1 | -329.73 Thousand CAD | 50.39% |
| 2016 Q3 | 74.97 Thousand CAD | 181.53% |
| 2016 Q2 | -91.95 Thousand CAD | -15.4% |
| 2016 Q1 | -79.68 Thousand CAD | 77.96% |
| 2016 FY | -761.31 Thousand CAD | 32.91% |
| 2016 Q4 | -664.64 Thousand CAD | -986.53% |
| 2015 FY | -1.13 Million CAD | 44.35% |
| 2015 Q4 | -361.55 Thousand CAD | -28.21% |
| 2015 Q3 | -282.01 Thousand CAD | -32.74% |
| 2015 Q2 | -212.45 Thousand CAD | 23.8% |
| 2015 Q1 | -278.8 Thousand CAD | 56.79% |
| 2014 Q2 | -690.99 Thousand CAD | -101.52% |
| 2014 Q1 | -342.89 Thousand CAD | 45.59% |
| 2014 Q3 | -360.08 Thousand CAD | 47.89% |
| 2014 FY | -2.03 Million CAD | 65.39% |
| 2014 Q4 | -645.2 Thousand CAD | -79.18% |
| 2013 Q3 | -433.32 Thousand CAD | 1.0% |
| 2013 Q1 | -4.38 Million CAD | -111.82% |
| 2013 Q2 | -437.69 Thousand CAD | 90.03% |
| 2013 Q4 | -630.19 Thousand CAD | -45.43% |
| 2013 FY | -5.89 Million CAD | -78.51% |
| 2012 FY | -3.3 Million CAD | -79.28% |
| 2012 Q4 | -2.07 Million CAD | -428.61% |
| 2012 Q3 | -392.05 Thousand CAD | -9.38% |
| 2012 Q2 | -358.41 Thousand CAD | 24.89% |
| 2012 Q1 | -477.2 Thousand CAD | -116.98% |
| 2011 Q3 | -244.28 Thousand CAD | 75.78% |
| 2011 Q1 | -367.87 Thousand CAD | 14.19% |
| 2011 FY | -1.84 Million CAD | 9.95% |
| 2011 Q2 | -1 Million CAD | -174.2% |
| 2011 Q4 | -219.92 Thousand CAD | 9.97% |
| 2010 Q4 | -428.7 Thousand CAD | -8.25% |
| 2010 Q3 | -396.03 Thousand CAD | 34.38% |
| 2010 Q2 | -603.48 Thousand CAD | 2.02% |
| 2010 FY | -2.04 Million CAD | -13.2% |
| 2010 Q1 | -615.9 Thousand CAD | -91.06% |
| 2009 Q2 | -291.17 Thousand CAD | 9.48% |
| 2009 FY | -1.8 Million CAD | -42.63% |
| 2009 Q3 | -870.63 Thousand CAD | -199.01% |
| 2009 Q1 | -321.66 Thousand CAD | -124.6% |
| 2009 Q4 | -322.35 Thousand CAD | 62.97% |
| 2008 Q1 | -53.55 Thousand CAD | 43.02% |
| 2008 Q4 | 1.3 Million CAD | 158.73% |
| 2008 Q3 | -2.22 Million CAD | -658.64% |
| 2008 FY | -1.26 Million CAD | -808.38% |
| 2008 Q2 | -293.51 Thousand CAD | -448.06% |
| 2007 Q1 | -5644.00 CAD | 21.47% |
| 2007 Q3 | -39.44 Thousand CAD | -13180.13% |
| 2007 Q4 | -93.99 Thousand CAD | -138.32% |
| 2007 Q2 | -297.00 CAD | 94.74% |
| 2007 FY | -139.38 Thousand CAD | -3.59% |
| 2006 FY | -134.55 Thousand CAD | 0.0% |
| 2006 Q2 | -54.88 Thousand CAD | -29.5% |
| 2006 Q4 | -7187.00 CAD | 76.12% |
| 2006 Q1 | -42.38 Thousand CAD | 0.0% |
| 2006 Q3 | -30.09 Thousand CAD | 45.17% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | -1067.227% |
| Arrayit Corporation | -3.31 Million USD | -396.379% |
| Atlantic International Corp. | -5.62 Million USD | -192.45% |
| Biocept, Inc. | -32.08 Million USD | 48.709% |
| Bioqual, Inc. | 483.48 Thousand USD | 3504.042% |
| CardioGenics Holdings Inc | -1.91 Million USD | -758.826% |
| DermTech, Inc. | -100.88 Million USD | 83.687% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 100.813% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | 23.787% |
| iMD Companies, Inc. | -200.63 Thousand USD | -8102.863% |
| IDenta Corp. | 14.64 Thousand USD | 112486.623% |
| Interpace Biosciences, Inc. | 802 Thousand USD | 2152.107% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | 42638.957% |
| InVitro International | 1553.00 USD | 1059848.68% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | -91.549% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -28220.996% |
| Medical Imaging Corp. | -3.02 Million USD | -444.418% |
| NovelStem International Corp. | -4.18 Million USD | -293.043% |
| Optigenex Inc. | -2.89 Million USD | -467.952% |
| PharmChem, Inc. | 845.1 Thousand USD | 2047.445% |
| Proteome Sciences plc | -2.44 Million USD | -573.676% |
| Response Genetics, Inc | -20.18 Million USD | 18.461% |
| Rennova Health, Inc. | -3.29 Million USD | -399.776% |
| RushNet, Inc. | -607.02 Thousand USD | -2611.225% |
| ScreenPro Security Inc. | -2.24 Million USD | -631.863% |
| Stella Diagnostics Inc. | -5.7 Million USD | -188.359% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | -44.173% |
| Todos Medical Ltd. | -24.99 Million USD | 34.153% |